Iris lymphoma in a pediatric cardiac transplant recipient - Clinicopathologic findings

被引:21
作者
Chan, SM
Hutnik, CML
Heathcote, JG
Orton, RB
Banerjee, D
机构
[1] Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada
[2] London Hlth Sci Ctr, Dept Ophthalmol, London, ON, Canada
[3] Univ Western Ontario, London, ON, Canada
[4] St Josephs Hlth Ctr, Dept Pathol, London, ON, Canada
[5] Princess Margaret Hosp, Dept Lab Med & Pathobiol, Toronto, ON M4X 1K9, Canada
关键词
D O I
10.1016/S0161-6420(00)00172-X
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: lymphoproliferative disorder, Design: Methods: To report the unusual presentation of a confirmed iris lymphoma in the setting of posttransplant Case report with clinicopathologic findings. Methods: The medical record was reviewed for clinical manifestations, course of disease, and pathologic and radiologic findings. Results: A 4-year-old girl who had undergone a cardiac transplant at 3 months of age was found to have unilateral iris lesions associated with granulomatous uveitis. Her condition was unresponsive to local and systemic steroids, so she underwent an iris biopsy that was found to contain a B cell-derived monoclonal lymphoproliferation. Treatment with systemic chemotherapy including cyclophosphamide and prednisone resulted in a transient, partial response. Localized radiotherapy induced total regression of the iris lesions. She continues to be observed and has been free of recurrence or metastasis for the past 12 months. Conclusions: Because of the increased use of organ transplantation, eye care specialists should consider the diagnosis of intraocular lymphoma when confronted with uveitis-like syndrome unresponsive to topical steroid therapy, Although there are numerous treatment options for intraocular lymphoma, radiation therapy was found to be effective in the treatment of this case. Ophthalmology 2000; 107:1479-1482 (C) 2000 by the American Academy of Ophthalmology.
引用
收藏
页码:1479 / 1482
页数:4
相关论文
共 26 条
[1]  
BASGOZ N, 1995, INFECT DIS CLIN N AM, V9, P901
[2]   THERAPY FOR TRANSPLANT-RELATED LYMPHOPROLIFERATIVE DISEASES [J].
BENKERROU, M ;
DURANDY, A ;
FISCHER, A .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1993, 7 (02) :467-475
[3]   TREATMENT OF SEVERE EPSTEIN-BARR VIRUS-INDUCED POLYCLONAL LYMPHOCYTE-B PROLIFERATION BY ANTI-B-CELL MONOCLONAL-ANTIBODIES - 2 CASES AFTER HLA-MISMATCHED BONE-MARROW TRANSPLANTATION [J].
BLANCHE, S ;
LEDEIST, F ;
VEBER, F ;
LENOIR, G ;
FISCHER, AM ;
BROCHIER, J ;
BOUCHEIX, C ;
DELAAGE, M ;
GRISCELLI, C ;
FISCHER, A .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (02) :199-203
[4]   BILATERAL IRIS TUMORS IN AN IMMUNOSUPPRESSED CHILD [J].
BRODSKY, MC ;
CASTEEL, H ;
BARBER, LD ;
KLETZL, M ;
ROLOSON, GJ .
SURVEY OF OPHTHALMOLOGY, 1991, 36 (03) :217-222
[5]   ADVANCES IN THE DIAGNOSIS AND TREATMENT OF PRIMARY IMMUNODEFICIENCY DISEASES [J].
BUCKLEY, RH .
ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (02) :377-384
[6]   Primary intraocular posttransplantation lymphoproliferative disorder [J].
Clark, WL ;
Scott, IU ;
Murray, TG ;
Rosa, RH ;
Siatkowski, M ;
Langham, MR .
ARCHIVES OF OPHTHALMOLOGY, 1998, 116 (12) :1667-1669
[7]   Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy [J].
Darenkov, IA ;
Marcarelli, MA ;
Basadonna, GP ;
Friedman, AL ;
Lorber, KM ;
Howe, JG ;
Crouch, J ;
Crouch, J ;
Bia, MJ ;
Kliger, AS ;
Lorber, MI .
TRANSPLANTATION, 1997, 64 (06) :848-852
[8]  
DELONE P, 1995, TRANSPLANT P, V27, P58
[9]  
FERRY JA, 1996, SOLID ORGAN TRANSPLA, pCH12
[10]  
GallegoMelcon S, 1996, MED PEDIATR ONCOL, V27, P156, DOI 10.1002/(SICI)1096-911X(199609)27:3<156::AID-MPO4>3.0.CO